How can the stories and experiences of patients affected by antibiotic-resistant infections be used to advocate for policy changes and increased research funding?

Some P. aeruginosa are becoming more resistant to even antibiotics of last resort, and are described as multidrug-resistant. May 14, 2014 ... A Pseudomonas aeruginosa type VI secretion phospholipase D effector targets both prokaryotic and eukaryotic cells. Cell Host Microbe. 2014 May ... Our results suggest that ExoS facilitates P. aeruginosa penetration through the intestinal epithelial barrier by binding to FXYD3 and thereby impairing the ... Aug 9, 2017 ... Pseudomonas aeruginosa (P. aeruginosa) is a common Gram-negative, rod-shaped bacterium. It lives primarily in water, soil and vegetation. Clinical Signs. P. aeruginosa infections typically are contracted from heavily infested surfaces such as tubing or water tubs, and virtually any animal can ... Mar 31, 2015 ... We establish the P. aeruginosa essential genome with statistical precision in laboratory media and CF sputum. Dec 16, 2024 ... ... infection due to P aeruginosa. Secondary outcomes included all ... Pseudomonas aeruginosa infection. Infect Drug Resist. 2022; 15:655 ... P. aeruginosa is a bacterial pathogen that causes a variety of opportunistic infections, including pulmonary infections in cystic fibrosis patients. The mutant ... Samples taken should be pre-flush samples which means that they should be taken immediately after the outlet is opened and ideally after a significant period ... Mar 22, 2024 ... FDA has completed their review of the rationale document titled, “Piperacillin-Tazobactam Breakpoints for Pseudomonas aeruginosa” (MR15, ...